Catalysts for $ABVC
5 tracked
Jan 15, 2026
approval
FILKRI (FILGRASTIM-LAHA) — FDA approval
filgrastim biosimilar
→
Nov 20, 2025
approval
IMULDOSA (USTEKINUMAB-SRLF) — FDA approval
ustekinumab biosimilar
→
Oct 29, 2025
approval
OSVYRTI (denosumab-desu) — FDA approval
OSVYRTI
→
Mar 17, 2025
approval
IMULDOSA (USTEKINUMAB-SRLF) — FDA approval
ustekinumab biosimilar
→
Oct 10, 2024
approval
IMULDOSA (USTEKINUMAB-SRLF) — FDA approval
ustekinumab biosimilar
→